跳至主要内容
临床试验/NCT00938704
NCT00938704已完成4 期

Study to Compare the Efficacy and Safety of Two Non-Preserved Artificial Tears for the Treatment of Dry Eye Signs and Symptoms

Allergan0 个研究点目标入组 71 人开始时间: 2009年6月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
Allergan
入组人数
71
主要终点
Change From Baseline in Ocular Surface Disease Index (OSDI) at Week 2

研究概览

简要总结

To compare the efficacy and safety of two non-preserved artificial tears, (carboxymethylcellulose 0.5%, + glycerin 0.9% vs. sodium hyaluronate 0.18%) eye drops for the treatment of the signs and symptoms of dry eye disease.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Current use of an artificial tear product at least 2 times per day (e.g. for relief of dry eye symptoms of dryness).
  • Be likely to complete the entire course of study and to comply with appropriate instructions

排除标准

  • Have undergone refractive surgery (e.g., cataract surgery, PRK, LASIK, or any surgery involving a limbal or corneal incision) within the last 12 months.
  • Have uncontrolled systemic disease
  • Are currently using, or have used within 14 days of study enrollment, any ocular medications other than artificial tears
  • Have anticipated contact lens wear during the study
  • Have an active ocular infection

研究组 & 干预措施

1

Active Comparator

carboxymethylcellulose 0.5%, glycerin 0.9%

干预措施: carboxymethylcellulose 0.5% +glycerin 0.9% (Drug)

2

Active Comparator

sodium hyaluronate 0.18%

干预措施: sodium hyaluronate 0.18% (Drug)

结局指标

主要结局

Change From Baseline in Ocular Surface Disease Index (OSDI) at Week 2

时间窗: Baseline, Week 2

Change from baseline in OSDI at Week 2. The OSDI consists of 12 questions measuring the presence of ocular symptoms. Each of the 12 questions is assessed using a 5-point scale (0=none of the time; 4=all of the time). The score is converted to a 0-100 score where 0 is best and 100 is worst. Higher OSDI scores are associated with greater severity. A negative number change from baseline indicates improvement.

次要结局

  • Change From Baseline in Tear Breakup Time (TBUT) at Week 2(Baseline, Week 2)
  • Change From Baseline in Corneal Staining at Week 2(Baseline, Week 2)
  • Change From Baseline in Conjunctival Staining (Temporal) at Week 2(Baseline, Week 2)
  • Change From Baseline in Conjunctival Staining (Nasal) at Week 2(Baseline, Week 2)

研究者

发起方
Allergan
申办方类型
Industry
责任方
Sponsor

相似试验